Institute of Anatomy, University Leipzig, Liebigstrasse 13, 04103, Leipzig, Germany.
J Neuroimmune Pharmacol. 2013 Sep;8(4):763-73. doi: 10.1007/s11481-013-9473-5. Epub 2013 Jun 6.
The concept of a blood-brain barrier (BBB) dates back to experiments performed by Paul Ehrlich. Using "intravital tracers" which change their color depending on their oxidative state, he intended to estimate the oxygen consumption of the bodily organs. An important prerequisite of this approach, however, would have been an equal distribution of these tracers at the beginning of the experiment, but this was not what he found: Hydrophilic dyes uniformly did not reach the parenchyma, which led his student, the Berlin physician Lewandowski to claim that the capillary wall provides a barrier for certain molecules in the brain, but it was not before the golden era of electron microscopy that Reese and Karnovsky detected what they called "morphological barriers" of the BBB. In this article, we provide an overview of what maintains barrier function for blood-molecules, clarify that a BBB for solutes is neither mechanistically equal to a barrier for immune cells nor in regard to the sites of entry (capillaries versus post-capillary venules), formulate areas of lack of knowledge and consequently, raise open questions to be addressed in the future.
血脑屏障(BBB)的概念可以追溯到保罗·埃尔利希(Paul Ehrlich)进行的实验。他使用“活体示踪剂”,这些示踪剂根据其氧化状态改变颜色,旨在估计身体器官的耗氧量。然而,这种方法的一个重要前提是在实验开始时这些示踪剂的分布是均等的,但他发现并非如此:亲水性染料并没有均匀地到达实质组织,这使得他的学生、柏林医生莱万多夫斯基(Lewandowski)声称毛细血管壁为大脑中的某些分子提供了屏障,但直到电子显微镜的黄金时代,里斯(Reese)和卡诺夫斯基(Karnovsky)才发现了他们所谓的 BBB 的“形态屏障”。在本文中,我们概述了维持血分子屏障功能的因素,澄清了溶质的 BBB 在机制上既不等同于免疫细胞的屏障,也与进入部位(毛细血管与后微静脉)无关,并提出了知识空白领域,从而提出了未来需要解决的开放性问题。